American Society of Hematology

Fig. 3.

Fig. 3. Time to adverse event for Gaucher patients treated with alglucerase in seroconverted patients (A) and in nonseroconverted patients (B).

Time to adverse event for Gaucher patients treated with alglucerase in seroconverted patients (A) and in nonseroconverted patients (B).

This Feature Is Available To Subscribers Only

Sign In or Create an Account